Search

everythinglearnresearchcommunity

for

Search:↓

Intralesional triamcinolone acetonide is the most effective treatment for localized alopecia areata.

Contact sensitizers like DCP and SADBE are the most effective treatments for alopecia areata.

Alopecia areata is an unpredictable autoimmune hair loss condition, treated based on severity, with half of patients regrowing hair within a year without treatment.

Monthly oral corticosteroid pulses effectively treat widespread alopecia areata in young patients.

Some treatments can help with hair regrowth in alopecia areata, but results vary and long-term use is often needed without changing the disease's outcome.

New treatments for alopecia areata show promise, but no cure exists and responses to treatments vary.

New alopecia treatments aim for better results and fewer side effects.

Diphencyprone therapy for hair loss can cause vitiligo.

Hair follicles in people with alopecia have lower levels of a key blood vessel growth protein.

People with hair loss conditions experience more anxiety, depression, and a lower quality of life than those without these conditions.

CD8+ T cells are involved in alopecia areata and may cause disease relapse.

Alopecia areata causes significant emotional distress, including high rates of depression and anxiety.

Vitiligo is not linked to coeliac disease, but a small number of alopecia areata patients may have it, suggesting they should be tested for coeliac disease.

Alopecia areata was most common in people in their 30s and 40s, with some family history and a higher relapse rate, and larger bald areas responded better to specific immunotherapy.

Combining 5% minoxidil and 0.5% anthralin can help regrow hair in some severe alopecia areata patients.

The study concluded that immune cells attacking hair follicles cause hair loss in alopecia, with genetics and environment also playing a role, and highlighted the potential of certain treatments.

Using patients' own fat-derived cells to treat alopecia areata significantly improved hair growth and was safe.

Nail problems are common in people with alopecia areata, often leading to cosmetic and functional issues, but more research is needed for treatment guidelines.

Plasmacytoid dendritic cells are a key factor in causing hair loss in alopecia areata and could help differentiate it from other hair loss conditions.

Injecting platelet-rich plasma is a safe and effective way to treat hair loss.

Topical immunotherapy, especially with DPCP, is effective for treating severe alopecia areata.

Women with early hair loss have higher blood pressure and aldosterone; screening and treatment may help.

Sulfasalazine may help treat persistent alopecia areata.

The updated SALT II tool offers a more precise way to measure scalp hair loss.

Targeted cancer therapies have a significant but lower risk of causing hair loss compared to chemotherapy.

Cyclosporine showed some improvement in alopecia areata but results were not statistically significant.

Tofacitinib is effective and safe for treating severe hair loss in Korean patients.

No treatment is completely effective for alopecia totalis and alopecia universalis.

Combining diphenylcyclopropenone with anthralin is more effective for hair regrowth in alopecia areata than using diphenylcyclopropenone alone, but may cause more side effects.

Methotrexate is a promising and safe treatment for severe alopecia areata, with better results when combined with corticosteroids.